Back to FIL Ltd FIL Ltd

AXSM

9 quarters

Position history for FIL LtdFIL Ltd's holdings in Axsome Therapeutics, Inc.

No. FIL exited its AXSM (Axsome Therapeutics) position in Q3 2021. Its Q2 2021 13F listed 10,176 shares worth $686,000. FIL first reported AXSM in Q3 2019 and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$4.3M

Total Shares Change

-210,253

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q3
Latest
Exited
0
-100.0%
$00.0%$32.96
0
2021-Q2
Unchanged
10,176
0.0%
$686,0000.0%$67.46
0
2021-Q1
Increased
10,176
+135x
$576,0000.0%$56.62
39
2020-Q4
Unchanged
75
0.0%
$6,0000.0%$81.47
0
2020-Q3
Increased
75
+114.3%
$5,0000.0%$71.25
17
2020-Q2
Decreased
35
-100.0%
$3,0000.0%$82.28
0
2020-Q1
Increased
265,085
+33.1%
$15.6M0.0%$58.83
36
2019-Q4
Decreased
199,151
-5.3%
$20.6M0.0%$103.36
0
2019-Q3
New
210,253
-
$4.3M0.0%$20.24
37

Other major holders of AXSM: Vanguard Group Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used